BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Treatment
30 results:

  • 1. Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer.
    Shim SH; Lee JY; Lee YY; Park JY; Lee YJ; Kim SI; Han GH; Yang EJ; Noh JJ; Yim GW; Son JH; Kim NK; Kim TH; Kong TW; Choi YJ; Cho A; Lim H; Jang EB; Cho HW; Suh DH
    J Gynecol Oncol; 2024 Mar; 35(2):e66. PubMed ID: 38330382
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The SGK3-Catalase antioxidant signaling axis drives cervical cancer growth and therapy resistance.
    Wang M; Liu J; Liao X; Yi Y; Xue Y; Yang L; Cheng H; Liu P
    Redox Biol; 2023 Nov; 67():102931. PubMed ID: 37866161
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Differentiated Thyroid cancer in Adolescents: Single Center Experience and Considerations for Surgical Management and Radioiodine treatment.
    Chiapponi C; Hartmann MJM; Decarolis B; Simon T; Bruns CJ; Faust M; Schultheis AM; Schmidt M; Alakus H
    J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):257-263. PubMed ID: 36987773
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The HPV16E7 Affibody as a Novel Potential Therapeutic Agent for Treating cervical cancer Is Likely Internalized through Dynamin and Caveolin-1 Dependent Endocytosis.
    Zhang Q; Zhu H; Cui Z; Li Y; Zhuo J; Ye J; Zhang Z; Lian Z; Du Q; Zhao KN; Zhang L; Jiang P
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009008
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Accurate preoperative staging with [
    Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
    Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Late follow-up of genital and ophthalmologic chronic graft-vs-host disease in females after allogeneic stem cell transplantation.
    Smith Knutsson E; Nicklasson M; Björk Y; Stenberg K; Sundfeldt K; Brune M
    Acta Obstet Gynecol Scand; 2022 Mar; 101(3):364-373. PubMed ID: 34962288
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. lncRNA TPT1‑AS1 knockdown inhibits liver cancer cell proliferation, migration and invasion.
    Li H; Jin J; Xian J; Wang W
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34498708
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Inhibiting TLR9 Signaling Stimulates Apoptosis and Cell Cycle Arrest, and Alleviates Angiogenic Property in Human cervical cancer Cells.
    Wang L; Zhang S; Cai H; Qi Q; Zhang C; Qi Z; Huang C
    Endocr Metab Immune Disord Drug Targets; 2022; 22(5):510-517. PubMed ID: 34161216
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Chrysin inhibits propagation of HeLa cells by attenuating cell survival and inducing apoptotic pathways.
    Raina R; Afroze N; Kedhari Sundaram M; Haque S; Bajbouj K; Hamad M; Hussain A
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2206-2220. PubMed ID: 33755959
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Silencing of circular RNA_0000326 inhibits cervical cancer cell proliferation, migration and invasion by boosting microRNA-338-3p-dependent down-regulation of cdk4.
    Wang Z; Ren C; Yang L; Zhang X; Liu J; Zhu Y; Jiang D
    Aging (Albany NY); 2021 Mar; 13(6):9119-9134. PubMed ID: 33735107
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Glycyrrhizin Mediates Downregulation of Notch Pathway Resulting in Initiation of Apoptosis and Disruption in the Cell Cycle Progression in cervical cancer Cells.
    Ahmad A; Tiwari RK; Saeed M; Ahmad I; Ansari IA
    Nutr Cancer; 2022; 74(2):622-639. PubMed ID: 33691557
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Organosulphur Compounds Induce Apoptosis and Cell Cycle Arrest in cervical cancer Cells via Downregulation of HPV E6 and E7 Oncogenes.
    Ansari IA; Ahmad A; Imran MA; Saeed M; Ahmad I
    Anticancer Agents Med Chem; 2021; 21(3):393-405. PubMed ID: 32819236
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Abemaciclib sensitizes HPV-negative cervical cancer to chemotherapy via specifically suppressing cdk4/6-Rb-E2F and mTOR pathways.
    Liu Y; Zhao R; Fang S; Li Q; Jin Y; Liu B
    Fundam Clin Pharmacol; 2021 Feb; 35(1):156-164. PubMed ID: 32446293
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Sarcoidosis-like reaction during palbociclib treatment for metastatic breast cancer: A case report.
    Stoffaës L; Dumazet A; Deslee G; Mohammad Muttaqi Z; Didier K; Botsen D
    Breast J; 2020 Jun; 26(6):1239-1241. PubMed ID: 32275106
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo.
    Xiong Y; Li T; Assani G; Ling H; Zhou Q; Zeng Y; Zhou F; Zhou Y
    Biomed Pharmacother; 2019 Apr; 112():108602. PubMed ID: 30784916
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Down-regulation of long non-coding RNA ANRIL inhibits the proliferation, migration and invasion of cervical cancer cells.
    Zhang WY; Liu YJ; He Y; Chen P
    Cancer Biomark; 2018; 23(2):243-253. PubMed ID: 30198868
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. LncRNA NEAT1 regulates cervical carcinoma proliferation and invasion by targeting AKT/PI3K.
    Guo HM; Yang SH; Zhao SZ; Li L; Yan MT; Fan MC
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4090-4097. PubMed ID: 30024596
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The poly (ADP-ribose) polymerase inhibitor rucaparib suppresses proliferation and serves as an effective radiosensitizer in cervical cancer.
    Tang M; Liu Q; Zhou L; Chen L; Yang X; Yu J; Wang Y; Qiu H
    Invest New Drugs; 2019 Feb; 37(1):65-75. PubMed ID: 29872938
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel.
    Li J; Chen L; Liu Q; Tang M; Wang Y; Yu J
    Cancer Biol Ther; 2018 Jun; 19(6):507-517. PubMed ID: 29400636
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer.
    Sikander M; Hafeez BB; Malik S; Alsayari A; Halaweish FT; Yallapu MM; Chauhan SC; Jaggi M
    Sci Rep; 2016 Nov; 6():36594. PubMed ID: 27824155
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.